Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Malaria Journal

Figure 3

From: Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study

Figure 3

Probability of parasitological failure by microscopy in Burkina-Faso and Mali. Notes: This graph shows the crude and PCR adjusted risk of parasitological failure in Mali and Burkina-Faso. Treatment failure was defined according to the standard WHO criteria and the cumulative risk of recurrence was determined using Kaplan-Meier survival analysis. Blue lines represent Mali and red lines Burkina-Faso. Panel A and panel B represent survival analysis for crude and PCR adjusted analysis, respectively.

Back to article page